SPONSOR
Prince of Wales Hospital, Shatin, Hong Kong
Total Trials
2
Recruiting
2
Phases
Phase 4
Prince of Wales Hospital, Shatin, Hong Kong is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Sarcopenia in Elderly, Aortic Valve Disease.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Prince of Wales Hospital, Shatin, Hong Kong
How many clinical trials has Prince of Wales Hospital, Shatin, Hong Kong sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Prince of Wales Hospital, Shatin, Hong Kong, of which 2 are actively recruiting participants. These trials cover conditions including Sarcopenia in Elderly, Aortic Valve Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Prince of Wales Hospital, Shatin, Hong Kong research focus on?
Prince of Wales Hospital, Shatin, Hong Kong clinical trials span Sarcopenia in Elderly, Aortic Valve Disease. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Prince of Wales Hospital, Shatin, Hong Kong clinical trial?
To participate in a Prince of Wales Hospital, Shatin, Hong Kong trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Prince of Wales Hospital, Shatin, Hong Kong trials with current recruitment status updated daily.
Clinical Trials by Prince of Wales Hospital, Shatin, Hong Kong
NCT06643780 Phase 4
Recruiting
RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis
Sarcopenia in Elderly
NCT07021612
Recruiting
A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation
Aortic Valve Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology